Quarterly report [Sections 13 or 15(d)]

SEGMENT INFORMATION (Tables)

v3.25.3
SEGMENT INFORMATION (Tables)
9 Months Ended
Sep. 30, 2025
SEGMENT INFORMATION  
Schedule of Segment Reporting income or loss and total assets

 

 

Three months ended

September 30,

 

 

Nine months ended

September 30,

 

 

 

2025

 

 

2024

 

 

2025

 

 

2024

 

Revenues, net

 

$ 635,224

 

 

$ -

 

 

$ 948,362

 

 

$ 7,665

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cost of implants and other costs

 

 

358,812

 

 

 

-

 

 

 

358,813

 

 

 

1,667

 

Research and development

 

 

1,004,660

 

 

 

460,138

 

 

 

1,463,439

 

 

 

1,210,334

 

Selling, general and administrative

 

 

1,145,353

 

 

 

1,192,869

 

 

 

3,254,760

 

 

 

2,773,288

 

Depreciation and amortization

 

 

71,986

 

 

 

6,714

 

 

 

168,807

 

 

 

20,141

 

Total operating expenses

 

$ 2,580,811

 

 

$ 1,659,721

 

 

$ 5,245,819

 

 

$ 4,005,430